Showing results (31-40 of 36) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Biomed Research International|March 20, 2020
Astragalus membranaceus-Derived Anti-Programmed Death-1 Monoclonal Antibodies with Immunomodulatory Therapeutic Effects against TumorsFu-Ling Chang, Keng-Chang Tsai, Tsai-Yu Lin, et al.Frontiers in Pharmacology|October 3, 2025
Toxicological assessment of novel Anti-COVID traditional Chinese medicine formulae NRICM101 and NRICM102: a comprehensive study on safety and genotoxicityChun-Tang Chiou, Chao-Lin Chang, Yu-Hwei Tseng, et al.Pharmacological Research|September 5, 2022
Targeting spike protein-induced TLR/NET axis by COVID-19 therapeutic NRICM102 ameliorates pulmonary embolism and fibrosisWen-Chi Wei, Chia-Ching Liaw, Keng-Chang Tsai, et al.Frontiers in Pharmacology|June 20, 2025
Synergistic protective effects of TCM formula NRICM102 and <i>N</i>-acetylcysteine against hepatorenal injury in a mouse model of bongkrekic acid poisoningYuh-Chiang Shen, Yea-Hwey Wang, Kuo-Tong Liou, et al.Journal of Traditional and Complementary Medicine|November 20, 2025
Evaluating the antiviral efficacy and specificity of chlorogenic acid and related herbal extracts against SARS-CoV-2 variants via spike protein binding interventionWen-Yu Hsieh, Chu-Nien Yu, Chang-Chang Chen, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 29, 2020
A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: A bedside-to-bench studyKeng-Chang Tsai, Yi-Chia Huang, Chia-Ching Liaw, et al.Pageof 4